Hyperpolarised 13C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer

Hyperpolarised magnetic resonance imaging (HP 13C-MRI) is an emerging clinical technique to detect [1-13C]lactate production in prostate cancer (PCa) following intravenous injection of hyperpolarised [1-13C]pyruvate. Here we differentiate clinically significant PCa from indolent disease in a low/int...

Полное описание

Библиографические подробности
Главные авторы: Sushentsev, N, McLean, MA, Warren, AY, Benjamin, AJV, Brodie, C, Frary, A, Gill, AB, Jones, J, Kaggie, JD, Lamb, BW, Locke, MJ, Miller, JL, Mills, IG, Priest, AN, Robb, FJL, Shah, N, Schulte, RS, Graves, MJ, Gnanapragasam, VJ, Brindle, KM, Barrett, T, Gallagher, FA
Формат: Journal article
Язык:English
Опубликовано: Springer Nature 2022
_version_ 1826307463053312000
author Sushentsev, N
McLean, MA
Warren, AY
Benjamin, AJV
Brodie, C
Frary, A
Gill, AB
Jones, J
Kaggie, JD
Lamb, BW
Locke, MJ
Miller, JL
Mills, IG
Priest, AN
Robb, FJL
Shah, N
Schulte, RS
Graves, MJ
Gnanapragasam, VJ
Brindle, KM
Barrett, T
Gallagher, FA
author_facet Sushentsev, N
McLean, MA
Warren, AY
Benjamin, AJV
Brodie, C
Frary, A
Gill, AB
Jones, J
Kaggie, JD
Lamb, BW
Locke, MJ
Miller, JL
Mills, IG
Priest, AN
Robb, FJL
Shah, N
Schulte, RS
Graves, MJ
Gnanapragasam, VJ
Brindle, KM
Barrett, T
Gallagher, FA
author_sort Sushentsev, N
collection OXFORD
description Hyperpolarised magnetic resonance imaging (HP 13C-MRI) is an emerging clinical technique to detect [1-13C]lactate production in prostate cancer (PCa) following intravenous injection of hyperpolarised [1-13C]pyruvate. Here we differentiate clinically significant PCa from indolent disease in a low/intermediate-risk population by correlating [1-13C]lactate labelling on MRI with the percentage of Gleason pattern 4 (%GP4) disease. Using immunohistochemistry and spatial transcriptomics, we show that HP 13C-MRI predominantly measures metabolism in the epithelial compartment of the tumour, rather than the stroma. MRI-derived tumour [1-13C]lactate labelling correlated with epithelial mRNA expression of the enzyme lactate dehydrogenase (LDHA and LDHB combined), and the ratio of lactate transporter expression between the epithelial and stromal compartments (epithelium-to-stroma MCT4). We observe similar changes in MCT4, LDHA, and LDHB between tumours with primary Gleason patterns 3 and 4 in an independent TCGA cohort. Therefore, HP 13C-MRI can metabolically phenotype clinically significant disease based on underlying metabolic differences in the epithelial and stromal tumour compartments.
first_indexed 2024-03-07T07:03:30Z
format Journal article
id oxford-uuid:99b6f8d1-76d4-4445-9502-a38233ec7f3d
institution University of Oxford
language English
last_indexed 2024-03-07T07:03:30Z
publishDate 2022
publisher Springer Nature
record_format dspace
spelling oxford-uuid:99b6f8d1-76d4-4445-9502-a38233ec7f3d2022-04-11T11:18:19ZHyperpolarised 13C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancerJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:99b6f8d1-76d4-4445-9502-a38233ec7f3dEnglishSymplectic ElementsSpringer Nature2022Sushentsev, NMcLean, MAWarren, AYBenjamin, AJVBrodie, CFrary, AGill, ABJones, JKaggie, JDLamb, BWLocke, MJMiller, JLMills, IGPriest, ANRobb, FJLShah, NSchulte, RSGraves, MJGnanapragasam, VJBrindle, KMBarrett, TGallagher, FAHyperpolarised magnetic resonance imaging (HP 13C-MRI) is an emerging clinical technique to detect [1-13C]lactate production in prostate cancer (PCa) following intravenous injection of hyperpolarised [1-13C]pyruvate. Here we differentiate clinically significant PCa from indolent disease in a low/intermediate-risk population by correlating [1-13C]lactate labelling on MRI with the percentage of Gleason pattern 4 (%GP4) disease. Using immunohistochemistry and spatial transcriptomics, we show that HP 13C-MRI predominantly measures metabolism in the epithelial compartment of the tumour, rather than the stroma. MRI-derived tumour [1-13C]lactate labelling correlated with epithelial mRNA expression of the enzyme lactate dehydrogenase (LDHA and LDHB combined), and the ratio of lactate transporter expression between the epithelial and stromal compartments (epithelium-to-stroma MCT4). We observe similar changes in MCT4, LDHA, and LDHB between tumours with primary Gleason patterns 3 and 4 in an independent TCGA cohort. Therefore, HP 13C-MRI can metabolically phenotype clinically significant disease based on underlying metabolic differences in the epithelial and stromal tumour compartments.
spellingShingle Sushentsev, N
McLean, MA
Warren, AY
Benjamin, AJV
Brodie, C
Frary, A
Gill, AB
Jones, J
Kaggie, JD
Lamb, BW
Locke, MJ
Miller, JL
Mills, IG
Priest, AN
Robb, FJL
Shah, N
Schulte, RS
Graves, MJ
Gnanapragasam, VJ
Brindle, KM
Barrett, T
Gallagher, FA
Hyperpolarised 13C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer
title Hyperpolarised 13C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer
title_full Hyperpolarised 13C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer
title_fullStr Hyperpolarised 13C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer
title_full_unstemmed Hyperpolarised 13C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer
title_short Hyperpolarised 13C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer
title_sort hyperpolarised 13c mri identifies the emergence of a glycolytic cell population within intermediate risk human prostate cancer
work_keys_str_mv AT sushentsevn hyperpolarised13cmriidentifiestheemergenceofaglycolyticcellpopulationwithinintermediateriskhumanprostatecancer
AT mcleanma hyperpolarised13cmriidentifiestheemergenceofaglycolyticcellpopulationwithinintermediateriskhumanprostatecancer
AT warrenay hyperpolarised13cmriidentifiestheemergenceofaglycolyticcellpopulationwithinintermediateriskhumanprostatecancer
AT benjaminajv hyperpolarised13cmriidentifiestheemergenceofaglycolyticcellpopulationwithinintermediateriskhumanprostatecancer
AT brodiec hyperpolarised13cmriidentifiestheemergenceofaglycolyticcellpopulationwithinintermediateriskhumanprostatecancer
AT frarya hyperpolarised13cmriidentifiestheemergenceofaglycolyticcellpopulationwithinintermediateriskhumanprostatecancer
AT gillab hyperpolarised13cmriidentifiestheemergenceofaglycolyticcellpopulationwithinintermediateriskhumanprostatecancer
AT jonesj hyperpolarised13cmriidentifiestheemergenceofaglycolyticcellpopulationwithinintermediateriskhumanprostatecancer
AT kaggiejd hyperpolarised13cmriidentifiestheemergenceofaglycolyticcellpopulationwithinintermediateriskhumanprostatecancer
AT lambbw hyperpolarised13cmriidentifiestheemergenceofaglycolyticcellpopulationwithinintermediateriskhumanprostatecancer
AT lockemj hyperpolarised13cmriidentifiestheemergenceofaglycolyticcellpopulationwithinintermediateriskhumanprostatecancer
AT millerjl hyperpolarised13cmriidentifiestheemergenceofaglycolyticcellpopulationwithinintermediateriskhumanprostatecancer
AT millsig hyperpolarised13cmriidentifiestheemergenceofaglycolyticcellpopulationwithinintermediateriskhumanprostatecancer
AT priestan hyperpolarised13cmriidentifiestheemergenceofaglycolyticcellpopulationwithinintermediateriskhumanprostatecancer
AT robbfjl hyperpolarised13cmriidentifiestheemergenceofaglycolyticcellpopulationwithinintermediateriskhumanprostatecancer
AT shahn hyperpolarised13cmriidentifiestheemergenceofaglycolyticcellpopulationwithinintermediateriskhumanprostatecancer
AT schulters hyperpolarised13cmriidentifiestheemergenceofaglycolyticcellpopulationwithinintermediateriskhumanprostatecancer
AT gravesmj hyperpolarised13cmriidentifiestheemergenceofaglycolyticcellpopulationwithinintermediateriskhumanprostatecancer
AT gnanapragasamvj hyperpolarised13cmriidentifiestheemergenceofaglycolyticcellpopulationwithinintermediateriskhumanprostatecancer
AT brindlekm hyperpolarised13cmriidentifiestheemergenceofaglycolyticcellpopulationwithinintermediateriskhumanprostatecancer
AT barrettt hyperpolarised13cmriidentifiestheemergenceofaglycolyticcellpopulationwithinintermediateriskhumanprostatecancer
AT gallagherfa hyperpolarised13cmriidentifiestheemergenceofaglycolyticcellpopulationwithinintermediateriskhumanprostatecancer